AKASA has developed a smart automation technology aimed at enhancing the healthcare revenue cycle. The company's technology provides automation services specifically intended for healthcare revenue cycle management. It examines historical data, enabling the creation of new flows to eradicate manual work and propels efficiency and performance improvements for healthcare institutions. This allows AKASA's clients to address issues arising from financial failures.

Investors include:

Further Key Investors:

Optum Ventures, James Momtazee, Founders Circle Capital, Symphony Ventures (Ireland), Olive Capital (North America), BOND Capital (San Francisco), Rancilio Cube, Preface Ventures, Refactor Capital, Costanoa Ventures.

Looking to sell AKASA Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you